Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
BHST vs ELVA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ELVA Captures Overall Composite Edge (41.0 SELL vs 58.2 HOLD), While BHST Leads 4–2 on Growth & Valuation Pillars
ELVA Overall Winner
6-Pillar Tally: BHST 4 – 2 ELVA
Matrix Metrics: BHST 4 – 6 ELVA
As of Nov 20, 2026, Electrovaya Inc. Common Shares (ELVA) captures the overall head-to-head institutional edge over BioHarvest Sciences Inc. (BHST) on higher Unified Composite conviction (41.0/100 SELL vs. 58.2/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while BHST wins 4–2 across the 6-pillar growth and valuation breakdown. BHST trades at $1.30 (N/M Forward P/E, -18.0% operating margin) versus ELVA at $3.27 (18.4x Forward P/E, 9.3% operating margin).
- Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ELVA 41.0/100 SELL), ELVA captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.3% vs. -18.0% operating margin) and revenue trajectory (+3.4% vs. +3.8% YoY).
- Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile ELVA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About BHST vs ELVA
BHST
BioHarvest Sciences Inc. Common Stock
$1.30
-1.52% 1D
Market Cap
$29.9M
TTM Revenue
$35M
Forward P/E
N/M
Beta / 30D Vol
0.25β · 86% Vol
Unified Composite Score
58.2
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
ELVA
Head-to-Head Winner
Electrovaya Inc. Common Shares
$3.27
-11.86% 1D
Market Cap
$185.5M
TTM Revenue
$72M
Forward P/E
18.4x
Beta / 30D Vol
3.51β · 89% Vol
Unified Composite Score
41.0
SELL
Tech 25.0
Fund 48.0
Flow 66.0
Mom 59.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (BHST 4 – 2 ELVA)
1. Valuation Multiples
ELVA
Forward P/E
N/M
18.4x
Trailing P/E
N/M
37.1x
PEG Ratio
N/M
0.28x
EV / Revenue
0.7x
3.0x
2. Growth & Scale
BHST
Revenue Growth (YoY)
+3.8%
+3.4%
Earnings Growth (YoY)
+0.0%
-69.3%
TTM Revenue (USD)
$35M
$72M
Market Cap
$29.9M
$185.5M
3. Profitability & Quality
ELVA
Gross Margin
59.0%
33.0%
Operating Margin
-18.0%
9.3%
Net Profit Margin
-31.2%
6.1%
Return on Equity (ROE)
-142.5%
9.8%
4. Balance Sheet & Cash Flow
BHST
Cash Generation (TTM)
-$9.4M
-$37M
Cash Flow Margin
-26.6%
-51.1%
Net Cash / Leverage
$5.1M Net Cash
$28M Net Debt (0.61x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
BHST
Options Structure Phase
UNCLASSIFIED
BREAKDOWN
Current IV / %ile
N/A (N/A)
88.1% (28th %ile)
Put/Call OI Skew
N/A
0.91x (Balanced)
OBV Trend / Tech Phase
NEUTRAL · Markdown
DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat
BHST
OpEx & R&D Intensity
77.0% of Rev ($27M)
23.7% of Rev ($17M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Packaged Foods Operator
Electrical Equipment & Parts Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: BHST (4) vs ELVA (6)| Institutional Metric | BHST | ELVA | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $29.9M | $185.5M | ELVA | |
| Trailing P/E Ratio | N/M | 37.1x | ELVA | |
| Forward P/E Ratio | N/M | 18.4x | ELVA | |
| Revenue Growth (YoY) | +3.8% | +3.4% | BHST | |
| Operating Margin (TTM) | -18.0% | 9.3% | ELVA | |
| Net Profit Margin | -31.2% | 6.1% | ELVA | |
| Return on Equity (ROE) | -142.5% | 9.8% | ELVA | |
| 52-Week Range Position | 6% ($1–$7) | 0% ($3–$13) | BHST | |
| Beta / 30D Volatility | 0.25β · 86% Vol | 3.51β · 89% Vol | BHST | |
| Unified Institutional Score | 58.2 / 100 (HOLD) | 41.0 / 100 (SELL) | BHST | |
| Trailing 12M Revenue (USD) | $35M | $72M | Scale | |
| Gross Profit Margin (TTM) | 59.0% | 33.0% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 0.7x EV/Rev | 0.28x PEG · 3.0x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$9.4M ($5.1M Net Cash) | -$37M ($28M Net Debt (0.61x D/E)) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
BHST +14.5 pp
3M Horizon
BHST +12.32 pp
6M Horizon
BHST +3.62 pp
1Y Horizon
ELVA +51.59 pp
Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)
| Period | BHST Revenue | ELVA Revenue | BHST Op. Margin | ELVA Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| Q2 '25 | $30M | $70M | -21.3% | 11.5% | ELVA |
| Q3 '25 | $40M | $80M | -10.1% | 11.7% | ELVA |
| Q4 '25 | $40M | $60M | -12.4% | 8.8% | ELVA |
| Q1 '26 | $30M | $70M | -21.6% | 12.1% | ELVA |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
BHST
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
ELVA
BREAKDOWN
Current IV
88.1%
IV Percentile
28th %ile
Put/Call OI Skew
0.91x (Balanced)
IV Regime
Balanced (25th–60th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact ELVA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
BHST Moat Profile
Cyclical / Execution-Driven Positioning
Packaged Foods Operator
OpEx & R&D Reinvestment
77.0% of Rev ($27M)
90D Engineering Disclosures
0 Published
ELVA Moat Profile
Cyclical / Execution-Driven Positioning
Electrical Equipment & Parts Operator
OpEx & R&D Reinvestment
23.7% of Rev ($17M)
90D Engineering Disclosures
0 Published
Investor FAQ BHST vs ELVA Key Questions & Quantitative Answers
As of Nov 20, 2026, Electrovaya Inc. Common Shares (ELVA) captures the overall head-to-head institutional edge over BioHarvest Sciences Inc. (BHST) on higher Unified Composite conviction (41.0/100 SELL vs. 58.2/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while BHST wins 4–2 across the 6-pillar growth and valuation breakdown. BHST trades at $1.30 (N/M Forward P/E, -18.0% operating margin) versus ELVA at $3.27 (18.4x Forward P/E, 9.3% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ELVA 41.0/100 SELL), ELVA captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.3% vs. -18.0% operating margin) and revenue trajectory (+3.4% vs. +3.8% YoY). Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile ELVA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
BHST leads the Growth & Scale pillar: BHST posts +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin), compared with ELVA at +3.4% YoY revenue growth and -69.3% YoY earnings growth on $72M TTM revenue (33.0% gross margin, 9.3% operating margin). Across the 4-period historical trajectory (Q2 '25 to Q1 '26), BHST cumulative revenue shifted +0.0% while ELVA shifted +0.0%. In operating R&D and SG&A reinvestment, BHST deploys 77.0% of Rev ($27M) (0 90-day corporate R&D disclosures) versus 23.7% of Rev ($17M) (0 disclosures) for ELVA.
ELVA screens cheaper on headline valuation multiples. BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin), whereas ELVA trades at 18.4x Forward P/E, 37.1x Trailing P/E, 0.28x PEG, and 3.0x EV/Revenue (-51.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHST (-142.5% ROE) versus ELVA (9.8% ROE) capital efficiency.
In options market volatility and institutional positioning, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk). By comparison, ELVA carries 88.1% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.91x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.51β · 89% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
ELVA vs BHST · Reverse Pair
BHST vs ACOG
· Sector Peer
BHST vs KGEI
· Sector Peer
BHST vs OBIO
· Sector Peer
ELVA vs PPIH
· Sector Peer
ELVA vs TOYO
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem